Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.23 (
MMP
)
4,246
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The function of the
putative metalloproteinase
encoded by the vaccinia virus
G1L
gene is unknown. To address this question, we have generated a vaccinia virus strain in which expression of the
G1L
gene is dependent on the addition of tetracycline (TET) when infection proceeds in a cell line expressing the tetracycline repressor. The vvtetOG1L virus replicated similarly to wild-type Western Reserve (WR) virus in these cells when TET was present but was arrested at a late stage in viral maturation in the absence of TET. This arrest resulted in the accumulation of 98.5% round immature virus particles compared to 6.9% at a similar time point when TET was present. Likewise, the titer of infectious virus progeny decreased by 98.9% +/- 0.97% when the vvtetOG1L virus was propagated in the absence of TET. Mutant virus replication was partially rescued by plasmid-encoded
G1L
, but not by
G1L
containing an HXXEH motif mutated to RXXQR. Modeling of
G1L
revealed a predicted structural similarity to the alpha-subunit of Saccharomyces cerevisiae mitochondrial processing peptidase (alpha-MPP). The HXXEH motif of
G1L
perfectly overlaps the HXXDR motif of alpha-MPP in this model. These results demonstrate that
G1L
is essential for virus maturation and suggest that
G1L
is a metalloproteinase with structural homology to alpha-MPP. However, no obvious effects on the expression and processing of the vaccinia virus major core proteins were observed in the
G1L
conditional mutant in the absence of TET compared to results for the TET and wild-type WR controls, suggesting that
G1L
activity is required after this step in viral morphogenesis.
...
PMID:The vaccinia virus G1L putative metalloproteinase is essential for viral replication in vivo. 1533 28